BIOMOTCPharmaceutical PreparationsFiscal year ends December 31
BIOMOLECULAR LIFE HOLDINGS, INC.
Financials through Q3 FY2015, quarter ended Sep 30, 2015Last filing: 10-Q on Nov 19, 2015
$0.79−0.02 (-2.47%)
Close on Oct 19, 2026
- Market cap
- $67.51M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$0.2100 (−21.00%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Split
BIOMOLECULAR LIFE HOLDINGS, INC. reported revenue of $0 for the twelve months to Sep 30, 2015. Free cash flow was -$1.91M.
Revenue
$0
TTM Q3 2015
Operating income
-$2.73M
TTM Q3 2015
Free cash flow
-$1.91M
FY2014
EPS, diluted
-$0.07
TTM Q3 2015
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2015
Valuation
- Market cap
- $67.51M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- -2.83%
Fundamentals
- Revenue
- $0
- Net income
- -$4.30M
- EPS, diluted
- -$0.07
- Free cash flow
- -$1.91M
- Book value per share
- -$0.05
- Diluted shares
- 85M
Three years at a glance
Fiscal years 2012 to 2014 and trailing twelve months, USD
Revenue
$0
Operating income
-$2.73M
Net income
-$4.30M
EPS, diluted
-$0.07
Free cash flow
–
Reported periodTrailing twelve months